Treatment of Recurrent or Progressive Meningiomas With the Radiolabelled Somatostatin Antagonist 177Lu-satoreotide
Clinical trial NCT04997317 · RECRUITING
Trial details
- NCT number
- NCT04997317
- Sponsor
- University Hospital, Basel, Switzerland
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-21
- Primary completion
- 2026-12-31
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.